[HTML][HTML] Peptide-based agents for cancer treatment: current applications and future directions

NTT Nhàn, T Yamada, KH Yamada - International Journal of Molecular …, 2023 - mdpi.com
Peptide-based strategies have received an enormous amount of attention because of their
specificity and applicability. Their specificity and tumor-targeting ability are applied to …

[HTML][HTML] Latest advances in hepatocellular carcinoma management and prevention through advanced technologies

TA Addissouky, IETE Sayed, MMA Ali, Y Wang… - Egyptian Liver …, 2024 - Springer
Background Hepatocellular carcinoma (HCC) is a common type of liver cancer, with a high
mortality rate. Hepatocellular carcinoma is a type of liver cancer that can be effectively …

[HTML][HTML] Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of Breast Cancer Using NIR-IIb Imaging

YY Zhu, L Song, YQ Zhang, WL Liu, WL Chen, WL Gao… - Cancer Research, 2023 - AACR
Sentinel lymph node (SLN) biopsy plays a critical role in axillary staging of breast cancer.
However, traditional SLN mapping does not accurately discern the presence or absence of …

[HTML][HTML] The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic

S Pricl - Pharmaceutics, 2023 - mdpi.com
COST Action CA17140 Cancer Nanomedicine—from the bench to the bedside
(Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from …

RNA-cleaving DNAzymes for accurate biosensing and gene therapy

X Gao, Y Liu, W Huo, Y Song, Y Chen, J Zhang, X Yang… - Nanoscale, 2023 - pubs.rsc.org
RNA-cleaving DNAzymes, which are single-stranded catalytic DNA, have attracted
considerable attention in bioanalysis and biomedical applications because of their high …

[HTML][HTML] Single domain Camelid antibody fragments for molecular imaging and therapy of cancer

S Li, SJM Hoefnagel, KK Krishnadath - Frontiers in Oncology, 2023 - frontiersin.org
Despite innovations in cancer therapeutics, cancer remains associated with high mortality
and is one of biggest health challenges worldwide. Therefore, developing precise cancer …

[HTML][HTML] Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy

N Magro, M Oteo, E Romero… - Nuclear Medicine and …, 2024 - Elsevier
Purpose Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast
cancer that lacks effective diagnostic and therapeutic options. Membrane type 1 matrix …

[HTML][HTML] Preclinical Evaluation of a Novel High-Affinity Radioligand [99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

E Bezverkhniaia, P Kanellopoulos… - International Journal of …, 2023 - mdpi.com
Radionuclide imaging using radiolabeled inhibitors of prostate-specific membrane antigen
(PSMA) can be used for the staging of prostate cancer. Previously, we optimized the Glu …

[HTML][HTML] Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150

A Mang, W Zou, V Rolny, M Reck, D Cigoianu… - Tumor …, 2024 - content.iospress.com
BACKGROUND: Patients with non-small cell lung cancer (NSCLC) and stable disease (SD)
have an unmet clinical need to help guide early treatment adjustments. OBJECTIVE: To …

[HTML][HTML] Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy

A Lauriola, P Davalli, G Marverti, S Santi, A Caporali… - Cancers, 2023 - mdpi.com
Simple Summary Although immunotherapy has improved the treatment and outcome of
cancer patients, there are still limitations to face because most patients cannot receive …